CervoMed Inc. — Director's Dealing 2016

Jul 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Diffusion Pharmaceuticals Inc. (DFFN)
CIK: 0001053691
Period of Report: 2016-07-21

Reporting Person: Adams Robert W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-07-21	Stock Option (Right to Buy)	$0.90	A	58473	Acquired	2026-07-21	Common Stock (58473)	Direct

Footnotes

F1: Option will vest monthly in equal 1/36th increments until fully vested.